| Sep 19, 2025 |
Sep 22, 2025 |
Kropotova Alexandra
|
CHIEF MEDICAL OFFICER |
Neutral |
47.5
|
-1,977
|
-4.18%
|
✗
|
- |
| Aug 26, 2025 |
Aug 28, 2025 |
Reich Samuel J
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 26, 2025 |
Aug 28, 2025 |
To Lucy
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 26, 2025 |
Aug 28, 2025 |
Kropotova Alexandra
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 26, 2025 |
Aug 28, 2025 |
Bausch Christoph Lawrence
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 26, 2025 |
Aug 28, 2025 |
Sullivan Eddie Joe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
Sessa Capital (Master), L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 22, 2025 |
Jul 24, 2025 |
Moin Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2025 |
Apr 1, 2025 |
Kropotova Alexandra
|
CHIEF MEDICAL OFFICER |
Neutral |
47.5
|
-1,179
|
-2.43%
|
✗
|
- |
| Dec 18, 2024 |
Dec 31, 2024 |
Kropotova Alexandra
|
CHIEF MEDICAL OFFICER |
Neutral |
47.5
|
-9,072
|
-15.78%
|
✗
|
- |
| Nov 1, 2024 |
Nov 5, 2024 |
Ellias Helen K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 12, 2024 |
Aug 13, 2024 |
To Lucy
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 31, 2024 |
To Lucy
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Spragens Jeffrey G
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Polvino William James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
SKYLER JAY S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Sullivan Eddie Joe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Lucera Erick
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
HAMILTON CHRISTINE E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Link David Charles
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Reich Samuel J
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 15, 2024 |
Jul 17, 2024 |
Giberson Scott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 24, 2024 |
Conley Mark William
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
May 14, 2024 |
SKYLER JAY S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 21, 2024 |
Feb 23, 2024 |
Kropotova Alexandra
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 21, 2024 |
Feb 23, 2024 |
Sullivan Eddie Joe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 21, 2024 |
Feb 23, 2024 |
Bausch Christoph Lawrence
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 21, 2024 |
Feb 23, 2024 |
King Michael
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 21, 2024 |
Feb 23, 2024 |
Reich Samuel J
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 7, 2023 |
Dec 8, 2023 |
Sullivan Eddie Joe
|
CEO |
Buy |
47.5
|
+1,740
|
0.03%
|
✗
|
$1.5K |
| Nov 30, 2023 |
Nov 30, 2023 |
King Michael
|
CFO |
Buy |
90.0
|
+5,000
|
100.00%
|
✗
|
$4.5K |
| Nov 29, 2023 |
Nov 30, 2023 |
Reich Samuel J
|
Chair |
Buy |
77.5
|
+11,000
|
1.46%
|
✗
|
$9.8K |
| Nov 24, 2023 |
Nov 28, 2023 |
Sessa Capital (Master), L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 24, 2023 |
Nov 28, 2023 |
Moin Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 24, 2023 |
Nov 28, 2023 |
Ellias Helen K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 22, 2023 |
Ellias Helen K.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 13, 2023 |
Nov 15, 2023 |
Moin Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 13, 2023 |
Nov 15, 2023 |
Sessa Capital (Master), L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 10, 2023 |
Nov 14, 2023 |
Moin Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 10, 2023 |
Nov 14, 2023 |
Sessa Capital (Master), L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 30, 2023 |
Nov 3, 2023 |
King Michael
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Nov 3, 2023 |
King Michael
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 23, 2023 |
Oct 24, 2023 |
Sessa Capital (Master), L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 23, 2023 |
Oct 24, 2023 |
Moin Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 10, 2023 |
Sessa Capital (Master), L.P.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 10, 2023 |
Moin Andrew
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 3, 2023 |
Apr 5, 2023 |
Lucera Erick
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 5, 2023 |
Lucera Erick
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2023 |
Mar 16, 2023 |
Kropotova Alexandra
|
Chief Medical Officer |
Neutral |
90.0
|
+275,000
|
100.00%
|
✗
|
- |
| Mar 14, 2023 |
Mar 16, 2023 |
Sullivan Eddie Joe
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2023 |
Mar 16, 2023 |
Reich Samuel J
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2023 |
Mar 16, 2023 |
Bausch Christoph Lawrence
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2023 |
Mar 16, 2023 |
Beyer Russell P
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Spragens Jeffrey G
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 28, 2023 |
Mar 2, 2023 |
Reich Samuel J
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 7, 2022 |
Feb 10, 2023 |
HAMILTON CHRISTINE E
|
Director |
Neutral |
27.5
|
-2,000,000
|
-19.80%
|
✗
|
- |
| Dec 7, 2022 |
Dec 9, 2022 |
HAMILTON CHRISTINE E
|
Director |
Neutral |
77.5
|
+82,987
|
1.03%
|
✗
|
- |
| Dec 7, 2022 |
Dec 9, 2022 |
Spragens Jeffrey G
|
Director |
Neutral |
90.0
|
+82,987
|
26.60%
|
✗
|
- |
| Dec 7, 2022 |
Dec 9, 2022 |
Link David Charles
|
Director |
Neutral |
90.0
|
+41,493
|
262.28%
|
✗
|
- |
| Sep 13, 2022 |
Sep 15, 2022 |
Reich Samuel J
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 13, 2022 |
Sep 15, 2022 |
Sullivan Eddie Joe
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 13, 2022 |
Sep 15, 2022 |
Giberson Scott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 13, 2022 |
Sep 15, 2022 |
Kropotova Alexandra
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 13, 2022 |
Sep 15, 2022 |
Bausch Christoph Lawrence
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 13, 2022 |
Sep 15, 2022 |
Beyer Russell P
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 13, 2022 |
Sep 14, 2022 |
HAMILTON CHRISTINE E
|
Director |
Buy |
60.0
|
+10,000
|
0.20%
|
✗
|
$7.3K |
| Sep 7, 2022 |
Sep 8, 2022 |
Sullivan Eddie Joe
|
CEO |
Buy |
61.3
|
+14,000
|
0.27%
|
✗
|
$10.3K |
|
Jul 13, 2022 |
Giberson Scott
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2022 |
Jun 7, 2022 |
Kropotova Alexandra
|
Chief Medical Officer |
Neutral |
90.0
|
+300,000
|
100.00%
|
✗
|
- |
|
Jun 7, 2022 |
Kropotova Alexandra
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 20, 2022 |
May 23, 2022 |
Spragens Jeffrey G
|
Director |
Neutral |
90.0
|
+299,002
|
2300.02%
|
✗
|
- |
| May 20, 2022 |
May 23, 2022 |
Reich Samuel J
|
Chair |
Neutral |
27.5
|
-2,293,126
|
-75.21%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Sullivan Eddie Joe
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Beyer Russell P
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Luke Thomas Charles
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Finnegan Frederick
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Reich Samuel J
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Ullerich Melissa Vera
|
Chief Communications Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Pommer Jerry Lynn
|
Chief Compliance Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Bausch Christoph Lawrence
|
Chief Science Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 16, 2022 |
Mar 18, 2022 |
Erickson Bruce Kipp
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Nov 24, 2021 |
Bausch Christoph Lawrence
|
Chief Science Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Nov 22, 2021 |
Polvino William James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 17, 2021 |
Nov 19, 2021 |
Beyer Russell P
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 17, 2021 |
Nov 19, 2021 |
Reich Samuel J
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 18, 2021 |
Nov 16, 2021 |
Beyer Russell P
|
CFO |
Sell |
90.0
|
+2,490
|
100.00%
|
✗
|
$2.2K |
| Oct 22, 2021 |
Oct 26, 2021 |
Carillo Carlos N
|
SVP Regulatory Affairs |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Erickson Bruce Kipp
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Wu Hua
|
SVP Research & Product Dev. |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Polvino William James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Finnegan Frederick
|
Chief Business Officer |
Neutral |
90.0
|
+38,596
|
100.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Hamilton Edward D.
|
10% Owner |
Neutral |
90.0
|
+10,102,435
|
100.00%
|
✗
|
- |
| Oct 19, 2021 |
Oct 26, 2021 |
Luke Thomas Charles
|
Chief Medical Officer |
Neutral |
90.0
|
+6,418
|
100.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Sullivan Eddie Joe
|
CEO |
Neutral |
90.0
|
+5,216,564
|
100.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Turner Mervyn
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Link David Charles
|
Director |
Neutral |
90.0
|
+27,917
|
100.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Bausch Christoph Lawrence
|
Chief Science Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Ullerich Melissa Vera
|
Chief Communications Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
HAMILTON CHRISTINE E
|
Director |
Neutral |
90.0
|
+10,102,435
|
100.00%
|
✗
|
- |
| Oct 22, 2021 |
Oct 26, 2021 |
Pommer Jerry Lynn
|
Chief Compliance Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |